RecruitingNot ApplicableNCT06882265

Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy

Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy : a Randomized Clinical Trial


Sponsor

University of Sao Paulo General Hospital

Enrollment

60 participants

Start Date

Nov 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Assess quality of life of patients using prolonged oxygen therapy


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether wearing a small device at home that tracks vital signs (like oxygen levels and heart rate) can help people with chronic lung diseases — specifically COPD (chronic obstructive pulmonary disease) or ILD (scarring/inflammation of the lungs) — who already use home oxygen therapy. **You may be eligible if...** - You are 18 or older - You have been diagnosed with COPD or ILD - Your condition has been stable for at least 6 weeks (no recent flare-ups or hospital stays) - You are already on home oxygen therapy and optimized medications - You have a compatible smartphone **You may NOT be eligible if...** - You have other significant lung diseases - You had a heart attack or unstable heart condition in the past 4 months - You received a lung transplant - You live outside the study coverage area Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALGroup Monitoring

In the intervention group (IG), participants receive a HR and SPO2 monitor watch and a pulse oximeter and will be monitored every 15 days by a nurse to check for non-adherence and/or technical failure, and/or exacerbations, and monthly to apply questionnaires.

BEHAVIORALControl Group

In the control group (CG), participants receive only a pulse oximeter and will be monitored monthly by a nurse to administer the questionnaires.


Locations(1)

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP),

São Paulo, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06882265


Related Trials